Pohang-si, South Korea

Hye Min Kim


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovative Contributions of Hye Min Kim in Drug Delivery Systems

Introduction: Hye Min Kim, a notable inventor based in Pohang-si, South Korea, has made significant strides in the field of biochemistry and drug delivery through his innovative patent. With a focus on hyaluronic acid-protein conjugates, his work promises to enhance the efficacy and longevity of protein drugs in treating liver diseases.

Latest Patents: Hye Min Kim holds a patent for “Hyaluronic acid-protein conjugates and method for preparing same.” This groundbreaking invention details a novel HA-protein conjugate where an HA-aldehyde derivative is conjugated to the N-terminus of a protein. The advantage of this conjugate lies in its bioconjugation efficiency and long-lasting medicinal effects. Specifically, it showcases excellent protein drug activities, ensuring that the hyaluronic acid is effectively targeted at the protein's N-terminus. The controllable liver-targeting properties that can be adjusted by changing the aldehyde substitution rate of the HA-aldehyde derivative highlight the potential of this invention in developing protein drugs necessary for liver disease treatment and overall optimized drug delivery systems.

Career Highlights: Currently, Hye Min Kim is associated with the Postech Academy-Industry Foundation, where he continues to work on pioneering projects aimed at enhancing drug efficacy and patient outcomes. His contributions to pharmaceutical sciences, particularly concerning protein drugs, reinforce his reputation as a forward-thinking innovator in the field.

Collaborations: Hye Min Kim has collaborated with esteemed colleagues such as Sei Kwang Hahn and Jeong A Yang. These partnerships not only exemplify his commitment to collective scientific advancement but also enhance the potential application of his patented technologies within the research community.

Conclusion: Hye Min Kim’s innovative patent for hyaluronic acid-protein conjugates underlines the significant advancements being made in drug delivery systems. His work not only exemplifies the intersection of chemistry and medicine but also holds the promise of transforming treatment modalities for liver diseases, undoubtedly benefiting countless patients in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…